1.Prognosis according to the timing of recurrence in breast cancer
Young Joo LEE ; Seung Pil JUNG ; Jeoung Won BAE ; Sun Moon YANG ; Ji Young YOU ; Soo Youn BAE
Annals of Surgical Treatment and Research 2023;104(1):1-9
Purpose:
Clinically, breast cancer can be divided into 4 subtypes based on the presence of hormone receptors, human epidermal growth factor receptor 2 (HER2), and Ki-67. Because the pattern and time of recurrence vary according to the subtype, we evaluated whether there was a difference in overall survival (OS) among the subtypes according to the time and type of recurrence.
Methods:
A total of 2,730 patients who underwent breast cancer surgery were analyzed. Early and late recurrence were defined as recurrence within and after 5 years of diagnosis, respectively. Recurrence type was categorized as locoregional recurrence or systemic recurrence.
Results:
Hormone receptor-positive tumors were significantly more frequent in the late recurrence group than in the early recurrence group (estrogen receptor positive, 47.8% [early] vs. 78.7% [late]). However, there was no difference in the rate of HER2 overexpression (HER2+, 38.1% [early] vs.39.0% [late]). In subgroup analysis, early recurrence was a significant prognostic factor for OS in all subtypes. However, late recurrence was a significant prognostic factor for OS only in the luminal B subtype (hazard ratio of 4.30). In addition, the luminal B type had the highest proportion in late recurrence patients (63.2%).
Conclusion
The luminal B subtype had a high rate of late recurrence, and late recurrence was a poor prognostic factor for OS only in this subgroup. Therefore, further targeted treatments for luminal B breast cancer are needed and patients with this subtype require close long-term surveillance.
2.Salmonella enterica serotype Choleraesuis infection in weaned pigs: a first clinicopathological case report from Korea
Jongho KIM ; Gyeongyeob KIM ; Hyun-Kyoung LEE ; Bo-Youn MOON ; Kichan LEE ; Jae-Won BYUN ; Ji-Young PARK ; Kyoung-Ki LEE ; Hye-Young JEOUNG ; Mi-Kyeong KO ; Bok-Kyung KU ; Yun Soo CHUNG ; You-Chan BAE
Korean Journal of Veterinary Research 2022;62(2):e14-
Salmonella enterica serotype Choleraesuis causes swine paratyphoid, with clinical findings of enterocolitis and septicemia. However, the clinicopathological features of S. Choleraesuis infections in pigs have not been reported in Korea. We describe the pathological findings of two weaned pigs with S. Choleraesuis infections, presenting with diarrhea, cough, and sudden death. Pathological examination indicated severe necrotic colitis in pig 1 and septicemic lesions in pig 2. Multidrug-resistant S. Choleraesuis was isolated from the pigs’ lungs and intestinal contents. Further research is required for the surveillance of S. Choleraesuis infections in pigs and the virulence estimation in the S. Choleraesuis isolates.
3.Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer
Soo Youn BAE ; Jeong Hyeon LEE ; Jeoung Won BAE ; Seung Pil JUNG
Annals of Surgical Treatment and Research 2020;98(6):291-298
Purpose:
Our previous studies suggested that p53-positive triple-negative breast cancer (TNBC) should be more sensitive to chemotherapy than p53-negative TNBC. The aim of this study was to determine whether p53 expression in TNBC could predict response to neoadjuvant chemotherapy and the resulting prognosis.
Methods:
From January 2009 to December 2017, TNBC patients who underwent neoadjuvant chemotherapy were reviewed, including a total of 31 TNBC patients who had clinical lymph node metastasis. The status of p53 expression in patients before and after chemotherapy was evaluated.
Results:
Two patients (22.2%, 2 of 9) achieved pCR in p53(+) TNBC and 4 patients (50%, 5 of 10) achieved pCR in p53(-) TNBC. There was no correlation between pCR rate and p53 expression (P = 0.350). Based on prechemotherapy p53 expression, there was no significant difference in disease-free survival (DFS) between p53(+) TNBC and p53(-) TNBC (P = 0.335). However, after chemotherapy, p53(+) TNBC had shown higher DFS than p53(-) TBNC (P = 0.099). Based on prechemotherapy p53 expression, p53(+) TNBC had better overall survival (OS) than p53(-) TNBC, but the difference was not statistically significant (P = 0.082). After chemotherapy, p53(+) TNBC showed significantly better OS than p53(-) TNBC (P = 0.018).
Conclusion
Immunohistochemically detected p53 expression in TNBC could not predict the response to neoadjuvant chemotherapy. However, p53(+) TNBC had a better OS than p53(-) TNBC in patients who underwent neoadjuvant chemotherapy.
4.Erratum: Validation of a Web-Based Tool to Predict the Ipsilateral Breast Tumor Recurrence (IBTR! 2.0) after Breast-Conserving Therapy for Korean Patients.
Seung Pil JUNG ; Sung Mo HUR ; Se Kyung LEE ; Sangmin KIM ; Min Young CHOI ; Soo Youn BAE ; Jiyoung KIM ; Min Kuk KIM ; Won Ho KIL ; Jun Ho CHOE ; Jung Han KIM ; Jee Soo KIM ; Seok Jin NAM ; Jeoung Won BAE ; Jeong Eon LEE
Journal of Breast Cancer 2017;20(1):117-117
This article was published with a misspelled the date of acceptance. The date of acceptance should be corrected as “March 7, 2013”.
Breast Neoplasms*
;
Breast*
;
Humans
;
Recurrence*
5.Significance of micrometastases in the calculation of the lymph node ratio for papillary thyroid cancer.
Young Woo CHANG ; Hwan Soo KIM ; Seung Pil JUNG ; Hoon Yub KIM ; Jae Bok LEE ; Jeoung Won BAE ; Gil Soo SON
Annals of Surgical Treatment and Research 2017;92(3):117-122
PURPOSE: The lymph node ratio (LNR) is an important prognostic factor in papillary thyroid carcinoma (PTC), but micrometastases in cervical lymph nodes (LNs) are not of great clinical importance. In this study, we analyzed the accuracy of prediction of the prognosis depending on whether micrometastases were included in the number of metastatic LNs when calculating LNR. METHODS: The study included 353 PTC patients who underwent total thyroidectomy with neck LN dissection, and calculated LNR by 2 methods according to whether micrometastases were included in the number of metastatic LNs: Method 1 did not and method 2 did include. To compare the predictive values of LNR by the 2 methods, correlation coefficients and receiver operating characteristic (ROC) curves were analyzed. RESULTS: Positive correlations were found between LNR and preablation stimulated thyroglobulin (sTg) levels in both methods, but the correlation between method 1 LNR and preablation sTg level was significantly stronger than that for method 2 (Fisher z = 1.7, P = 0.045). The areas under these 2 independent ROC curves were analyzed; the prognostic efficacy of method 1 LNR was more accurate than that of method 2 LNR, and the difference was statistically significant (P = 0.0001). CONCLUSION: Regional recurrence of PTC can be predicted more accurately by not including micrometastases in the number of metastatic LNs when calculating LNR.
Humans
;
Lymph Nodes*
;
Methods
;
Neck
;
Neoplasm Micrometastasis*
;
Prognosis
;
Recurrence
;
ROC Curve
;
Thyroglobulin
;
Thyroid Gland*
;
Thyroid Neoplasms*
;
Thyroidectomy
6.Extensive silicone lymphadenopathy after breast implant insertion mimicking malignant lymphadenopathy.
Youngseok LEE ; Sung Eun SONG ; Eul Sik YOON ; Jeoung Won BAE ; Seung Pil JUNG
Annals of Surgical Treatment and Research 2017;93(6):331-335
Silicone implants are widely used in aesthetic and reconstructive breast surgery. Silicone lymphadenopathy is a well-known rare complication of implant insertion. Silicone leakage from a rupture or silicone bleeding can accumulate in lymph nodes. Foreign body reactions in the affected lymph nodes may be misdiagnosed as metastasis or malignant lymphadeno pathy upon initial presentation if silicone lymphadenopathy is not considered in the initial diagnosis. We report a case of siliconoma with extensive involvement of multiple lymph nodes mimicking malignant features to emphasize that clinicians should carefully evaluate each patient's medical history and disease status during differential diagnosis.
Breast Implants*
;
Breast*
;
Diagnosis
;
Diagnosis, Differential
;
Foreign Bodies
;
Hemorrhage
;
Lymph Nodes
;
Lymphatic Diseases*
;
Neoplasm Metastasis
;
Rupture
;
Silicon*
;
Silicones*
7.Extensive silicone lymphadenopathy after breast implant insertion mimicking malignant lymphadenopathy.
Youngseok LEE ; Sung Eun SONG ; Eul Sik YOON ; Jeoung Won BAE ; Seung Pil JUNG
Annals of Surgical Treatment and Research 2017;93(6):331-335
Silicone implants are widely used in aesthetic and reconstructive breast surgery. Silicone lymphadenopathy is a well-known rare complication of implant insertion. Silicone leakage from a rupture or silicone bleeding can accumulate in lymph nodes. Foreign body reactions in the affected lymph nodes may be misdiagnosed as metastasis or malignant lymphadeno pathy upon initial presentation if silicone lymphadenopathy is not considered in the initial diagnosis. We report a case of siliconoma with extensive involvement of multiple lymph nodes mimicking malignant features to emphasize that clinicians should carefully evaluate each patient's medical history and disease status during differential diagnosis.
Breast Implants*
;
Breast*
;
Diagnosis
;
Diagnosis, Differential
;
Foreign Bodies
;
Hemorrhage
;
Lymph Nodes
;
Lymphatic Diseases*
;
Neoplasm Metastasis
;
Rupture
;
Silicon*
;
Silicones*
8.Evaluation of Prognostic Factors and Validation of Tumor Response Ratios after Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Tong MOON ; Dong Hui CHO ; Jung Min YOUN ; Jae Bok LEE ; Jeoung Won BAE ; Seung Pil JUNG
Journal of Breast Disease 2016;4(2):108-115
PURPOSE: In the treatment of breast cancer, neoadjuvant chemotherapy (NAC) is useful to reduce breast cancer size before surgical intervention. Patients who achieve a pathologic complete response (pCR) to NAC have improved overall survival (OS). However, the relationship between prognosis and partial response is yet unclear. In this study, we evaluated prognostic factors and the tumor response ratio (TRR) method among patients who received NAC. METHODS: Clinicopathologic factors were evaluated to predict OS. The TRR was calculated by dividing pathologic tumor size by clinical tumor size. TRRs were then categorized into four groups, and the survival times for the different TRR groups were compared using statistical evaluation. RESULTS: Clinical N stage (p=0.02), overall stage (p=0.04), pathologic N stage (p=0.03), hormone receptor status (p=0.01), and lymphovascular invasion (p=0.02) were significantly associated with OS. Pathologic overall stage and TRR did not correlate with OS. Patients with a pCR exhibited the best survival rates using the current staging system and the TRR method. CONCLUSION: Clinicopathologic factors can be easily applied to predict OS, and clinicians could use these parameters until an accurate, simple, and highly discriminatory methods is developed to assess breast cancer patients with a partial.
9.Primary Follicular Lymphoma in a Male Breast: A Case Report.
Seung Pil JUNG ; Kang Min HAN ; Seok Jin KIM ; Seok Jin NAM ; Jeoung Won BAE ; Jeong Eon LEE
Cancer Research and Treatment 2014;46(1):104-107
Primary breast lymphoma (PBL) is a rare disease, particularly in males. Diffuse large B cell lymphoma is the most common PBL, while follicular lymphoma is less common. Furthermore, primary follicular lymphoma of a male breast is rarely reported. We report a male patient with primary follicular lymphoma of the breast and hepatocellular carcinoma (HCC). A 46-year-old man was diagnosed with liver cirrhosis secondary to chronic hepatitis B infection. Ten years later, he underwent segmentectomy of the liver due to HCC. Another 5 months later, he presented with a painless mass in the right chest wall. The mass was diagnosed as follicular lymphoma of the breast. The stage was IEA and he did not receive adjuvant therapy. Although only a few cases have been reported, lymphoma should be considered as a possible cause of breast mass, even in male patients.
Breast*
;
Carcinoma, Hepatocellular
;
Hepatitis B, Chronic
;
Humans
;
Liver
;
Liver Cirrhosis
;
Lymphoma
;
Lymphoma, B-Cell
;
Lymphoma, Follicular*
;
Male*
;
Mastectomy, Segmental
;
Middle Aged
;
Rare Diseases
;
Thoracic Wall
10.Primary Follicular Lymphoma in a Male Breast: A Case Report.
Seung Pil JUNG ; Kang Min HAN ; Seok Jin KIM ; Seok Jin NAM ; Jeoung Won BAE ; Jeong Eon LEE
Cancer Research and Treatment 2014;46(1):104-107
Primary breast lymphoma (PBL) is a rare disease, particularly in males. Diffuse large B cell lymphoma is the most common PBL, while follicular lymphoma is less common. Furthermore, primary follicular lymphoma of a male breast is rarely reported. We report a male patient with primary follicular lymphoma of the breast and hepatocellular carcinoma (HCC). A 46-year-old man was diagnosed with liver cirrhosis secondary to chronic hepatitis B infection. Ten years later, he underwent segmentectomy of the liver due to HCC. Another 5 months later, he presented with a painless mass in the right chest wall. The mass was diagnosed as follicular lymphoma of the breast. The stage was IEA and he did not receive adjuvant therapy. Although only a few cases have been reported, lymphoma should be considered as a possible cause of breast mass, even in male patients.
Breast*
;
Carcinoma, Hepatocellular
;
Hepatitis B, Chronic
;
Humans
;
Liver
;
Liver Cirrhosis
;
Lymphoma
;
Lymphoma, B-Cell
;
Lymphoma, Follicular*
;
Male*
;
Mastectomy, Segmental
;
Middle Aged
;
Rare Diseases
;
Thoracic Wall

Result Analysis
Print
Save
E-mail